Huntington’s Disease Clinical Trials Corner: August 2023

In this edition of the Huntington’s Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Estevez-Fraga, Carlos, Tabrizi, Sarah J., Wild, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Clinical Trials Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473124/
https://www.ncbi.nlm.nih.gov/pubmed/37483021
http://dx.doi.org/10.3233/JHD-239001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473124/
https://www.ncbi.nlm.nih.gov/pubmed/37483021
http://dx.doi.org/10.3233/JHD-239001

Ejemplares similares